24 May 2013
Keywords: pharmacyclics, start, new, trial, xcytrin, firm, said
Article | 22 April 2002
US firm Pharmacyclics has said it will start an additional Phase IIIclinical trial of its lead product, Xcytrin (motexafin gadolinium)
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 April 2002
29 April 2002
23 May 2013
© 2013 thepharmaletter.com